Long Noncoding Rna Malat1 Acts As A Potential Biomarker in Cancer Diagnosis and Detection: A Meta-Analysis

References

• Siegel RL , MillerKD, JemalA. Cancer statistics, 2018. CA Cancer J. Clin.68 (1), 7–30 (2018).
   PubMed Web of Science ®Google Scholar
• Ferlay J , SoerjomataramI, DikshitRet al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer136 (5), E359–386 (2015).
   PubMed Web of Science ®Google Scholar
• Tsai MC , ManorO, WanYet al. Long noncoding RNA as modular scaffold of histone modification complexes. Science329 (5992), 689–693 (2010).
   PubMed Web of Science ®Google Scholar
• Zhang HM , YangFQ, ChenSJ, CheJ, ZhengJH. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma. Tumour Biol.36 (4), 2947–2955 (2015).
   PubMedGoogle Scholar
• Dhamija S , DiederichsS. From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis. Int. J. Cancer139 (2), 269–280 (2016).
   PubMed Web of Science ®Google Scholar
• Raveh E , MatoukIJ, GilonM, HochbergA. The H19 long non-coding RNA in cancer initiation, progression and metastasis – a proposed unifying theory. Mol. Cancer14, 184 (2015).
   PubMed Web of Science ®Google Scholar
• Yu X , LiZ. Long non-coding RNA HOTAIR: a novel oncogene (Review). Mol. Med. Rep.12 (4), 5611–5618 (2015).
   PubMed Web of Science ®Google Scholar
• Tripathi V , EllisJD, ShenZet al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell39 (6), 925–938 (2010).
   PubMed Web of Science ®Google Scholar
• Gutschner T , HammerleM, EissmannMet al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res.73 (3), 1180–1189 (2013).
   PubMed Web of Science ®Google Scholar
• Han Y , LiuY, NieL, GuiY, CaiZ. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder. Urology81 (1), 209e201–e207 (2013).
   Web of Science ®Google Scholar
• West JA , DavisCP, SunwooHet al. The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites. Mol. Cell55 (5), 791–802 (2014).
   PubMed Web of Science ®Google Scholar
• Wang J , SuL, ChenXet al. MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF. Biomed. Pharmacother.68 (5), 557–564 (2014).
   PubMed Web of Science ®Google Scholar
• Xu C , YangM, TianJ, WangX, LiZ. MALAT-1: a long non-coding RNA and its important 3’ end functional motif in colorectal cancer metastasis. Int. J. Oncol.39 (1), 169–175 (2011).
   PubMed Web of Science ®Google Scholar
• Schmidt LH , SpiekerT, KoschmiederSet al. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J. Thorac. Oncol.6 (12), 1984–1992 (2011).
   PubMed Web of Science ®Google Scholar
• Pang EJ , YangR, FuXB, LiuYF. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer. Tumour Biol, 36 (4), 2403–2407 (2015).
   PubMedGoogle Scholar
• Vamvakas EC . Meta-analyses of studies of the diagnostic accuracy of laboratory tests: a review of the concepts and methods. Arch. Pathol. Lab Med.122 (8), 675–686 (1998).
   PubMed Web of Science ®Google Scholar
• Rutter CM , GatsonisCA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat. Med.20 (19), 2865–2884 (2001).
   PubMed Web of Science ®Google Scholar
• Deeks JJ , MacaskillP, IrwigL. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol, 58 (9), 882–893 (2005).
   PubMed Web of Science ®Google Scholar
• Han J . The expression and clinical significance of long non-coding RNA MALAT1 in endometrial cancer. Chin. J. Fam. Plan. Gynecotokol.8 (6), 51–54 (2016).
   Google Scholar
• Tian Z , LiuL, LiaoJ. Expression and diagnostic values of lncRNA-Malat-1, P21 and GAS5 in colorectal cancer tissue. Acta Med. Univ. Sci. Technol. Huazhong46 (1), 10–14 (2017).
   Google Scholar
• Shi T , GaoG, CaoY. Expression of MALAT1 in serum of the patients with non-small cell lung cancer (NSCLC) and its clinical significance. Chin. J. Clin. Lab Sci.34 (2), 114–117 (2016).
   Google Scholar
• Wen Z , LiX. Diagnostic value of long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 in serum for clinical diagnosis of lung cancer. J. Clin. Pulmon. Med.21 (12), 2154–2158 (2016).
   Google Scholar
• Weber DG , JohnenG, CasjensSet al. Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer. BMC Res. Notes6, 518 (2013).
   PubMedGoogle Scholar
• Chen Q , SuY, HeXet al. Plasma long non-coding RNA MALAT1 is associated with distant metastasis in patients with epithelial ovarian cancer. Oncol Lett.12 (2), 1361–1366 (2016).
   PubMed Web of Science ®Google Scholar
• Konishi H , IchikawaD, YamamotoYet al. Plasma level of metastasis-associated lung adenocarcinoma transcript 1 is associated with liver damage and predicts development of hepatocellular carcinoma. Cancer Sci.107 (2), 149–154 (2016).
   PubMed Web of Science ®Google Scholar
• Li X , LiuY, ZhangY, YaoL, GaoY, HuiN. The effects of serum-based long non-coding RNA MALAT-1 detection in diagnosing ovarian cancer. Progress Mod. Biomed.16 (27), 5254–5257 (2016).
   Google Scholar
• Peng H , WangJ, LiJet al. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer. Life Sci.151, 235–242 (2016).
   PubMed Web of Science ®Google Scholar
• He B , ZengJ, ChaoWet al. Serum long non-coding RNAs MALAT1, AFAP1-AS1 and AL359062 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma. Oncotarget8 (25), 41166–41177 (2017).
   PubMedGoogle Scholar
• Huo Y , LiQ, WangXet al. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2. Oncotarget8 (29), 46993–47006 (2017).
   PubMedGoogle Scholar
• Sun KK , HuPP, XuF. Prognostic significance of long non-coding RNA MALAT1 for predicting the recurrence and metastasis of gallbladder cancer and its effect on cell proliferation, migration, invasion, and apoptosis. J. Cell. Biochem. (2017).
   Web of Science ®Google Scholar
• Diehl F , SchmidtK, ChotiMAet al. Circulating mutant DNA to assess tumor dynamics. Nat. Med.14 (9), 985–990 (2008).
   PubMed Web of Science ®Google Scholar
• Li S , WangQ, QiangQet al. Sp1-mediated transcriptional regulation of MALAT1 plays a critical role in tumor. J. Cancer Res. Clin. Oncol.141 (11), 1909–1920 (2015).
   PubMed Web of Science ®Google Scholar
• Wang X , LiM, WangZet al. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells. J. Biol. Chem.290 (7), 3925–3935 (2015).
   PubMed Web of Science ®Google Scholar
• Xia H , ChenQ, ChenYet al. The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis. Oncotarget7 (35), 56209–56218 (2016).
   PubMedGoogle Scholar
• Lijmer JG , BossuytPM, HeisterkampSH. Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat. Med.21 (11), 1525–1537 (2002).
   PubMed Web of Science ®Google Scholar
• Wang Z , WangX, ZhangD, YuY, CaiL, ZhangC. Long non-coding RNA urothelial carcinoma-associated 1 as a tumor biomarker for the diagnosis of urinary bladder cancer. Tumour Biol.39 (6), 1010428317709990 (2017).
   Google Scholar
• Zeng Y , WangT, LiuYet al. LncRNA PVT1 as an effective biomarker for cancer diagnosis and detection based on transcriptome data and meta-analysis. Oncotarget8 (43), 75455–75466 (2017).
   PubMedGoogle Scholar
• Wang X , ChenX, ZhangDet al. Prognostic and clinicopathological role of long non-coding RNA taurine upregulated 1 in various human malignancies: a systemic review and meta-analysis. Tumour Biol.39 (7), 1010428317714361 (2017).
   Google Scholar